-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) names Rajesh Asarpota as CFO
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
-
-
-
-
-
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
-
-
-
-
-
-
-
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
-
-
-
-
-
-
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
-
1,154,869 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

